These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 1432421)
21. Hyperornithinemia, hyperammonemia and homocitrullinuria--a case report and study of ornithine metabolism using in vivo deuterium labelling. Tsujino S; Suzuki T; Azuma T; Higa S; Sakoda S; Kishimoto S Clin Chim Acta; 1991 Sep; 201(1-2):129-33. PubMed ID: 1790616 [No Abstract] [Full Text] [Related]
22. The hyperornithinemia, hyperammonemia, homocitrullinuria syndrome: an ornithine transport defect remediable with ornithine supplements. Gordon BA; Gatfield DP; Haust MD Clin Invest Med; 1987 Jul; 10(4):329-36. PubMed ID: 3652557 [TBL] [Abstract][Full Text] [Related]
23. Hyperornithinemia-hyperammonemia-homocitrullinuria (HHH)-syndrome. Ultrastructural changes of mitochondria in cultured dermal fibroblasts of three patients. Haust MD; Dewar RA; Gatfield DP; Gordon BA Pathol Res Pract; 1996 Mar; 192(3):271-80. PubMed ID: 8739474 [TBL] [Abstract][Full Text] [Related]
24. Hyperornithinemia, hyperammonemia, and homocitrullinuria syndrome with evidence of mitochondrial dysfunction due to a novel SLC25A15 (ORNT1) gene mutation in a Palestinian family. Korman SH; Kanazawa N; Abu-Libdeh B; Gutman A; Tsujino S J Neurol Sci; 2004 Mar; 218(1-2):53-8. PubMed ID: 14759633 [TBL] [Abstract][Full Text] [Related]
25. Biochemical analysis of decreased ornithine transport activity in the liver mitochondria from patients with hyperornithinemia, hyperammonemia and homocitrullinuria. Inoue I; Saheki T; Kayanuma K; Uono M; Nakajima M; Takeshita K; Koike R; Yuasa T; Miyatake T; Sakoda K Biochim Biophys Acta; 1988 Jan; 964(1):90-5. PubMed ID: 3334877 [TBL] [Abstract][Full Text] [Related]
26. Hyperornithinemia, hyperammonemia, and homocitrullinuria: case report and biochemical study. Koike R; Fujimori K; Yuasa T; Miyatake T; Inoue I; Saheki T Neurology; 1987 Nov; 37(11):1813-5. PubMed ID: 3670619 [TBL] [Abstract][Full Text] [Related]
28. [Hyperornithinemia, hyperammonemia and homocitrullinuria due to a defect of mitochondrial membrane transport]. Oyanagi K Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):843-6. PubMed ID: 3270901 [No Abstract] [Full Text] [Related]
29. Ornithinemia, hyperammonemia, and homocitrullinuria. A disease associated with mental retardation and possibly caused by defective mitochondrial transport. Fell V; Pollitt RJ; Sampson GA; Wright T Am J Dis Child; 1974 May; 127(5):752-6. PubMed ID: 4825593 [No Abstract] [Full Text] [Related]
30. Ultrastructure of hepatic mitochondria in a child with hyperornithinemia, hyperammonemia, and homocitrullinuria. Haust MD; Gatfield PD; Gordon BA Hum Pathol; 1981 Mar; 12(3):212-22. PubMed ID: 7228016 [TBL] [Abstract][Full Text] [Related]
31. Conscientious metabolic monitoring on a patient with hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome undergoing anaesthesia. Mühling J; Dehne MG; Fuchs M; Sablotzki A; Weiss S; Spatz J; Hempelmann G Amino Acids; 2001; 21(3):303-18. PubMed ID: 11764411 [TBL] [Abstract][Full Text] [Related]
33. A new family affected by the syndrome of hyperornithinaemia, hyperammonaemia and homocitrullinuria. Rodes M; Ribes A; Pineda M; Alvarez L; Fabregas I; Fernandez Alvarez E; Coude FX; Grimber G J Inherit Metab Dis; 1987; 10(1):73-81. PubMed ID: 3106719 [TBL] [Abstract][Full Text] [Related]
34. Prenatal exclusion of the HHH syndrome. Gray RG; Green A; Hall S; McKeown C Prenat Diagn; 1995 May; 15(5):474-6. PubMed ID: 7644438 [TBL] [Abstract][Full Text] [Related]
35. Gamma-glutamylornithine excretion in patients with hyperornithinemia. Roesel RA; Coryell ME; Blankenship PR; Hommes FA Clin Chim Acta; 1984 Jul; 140(2):133-8. PubMed ID: 6547887 [TBL] [Abstract][Full Text] [Related]
37. Ciliated cultured dermal fibroblasts in a patient with hyperornithinemia, hyperammonemia and homocitrullinuria (HHH) syndrome. Haust MD Pathol Res Pract; 1995 Oct; 191(10):1062-5. PubMed ID: 8838382 [TBL] [Abstract][Full Text] [Related]
38. Clinical and molecular findings in hyperornithinemia-hyperammonemia-homocitrullinuria syndrome. Salvi S; Santorelli FM; Bertini E; Boldrini R; Meli C; Donati A; Burlina AB; Rizzo C; Di Capua M; Fariello G; Dionisi-Vici C Neurology; 2001 Sep; 57(5):911-4. PubMed ID: 11552031 [TBL] [Abstract][Full Text] [Related]
39. Three novel mutations (G27E, insAAC, R179X) in the ORNT1 gene of Japanese patients with hyperornithinemia, hyperammonemia, and homocitrullinuria syndrome. Tsujino S; Kanazawa N; Ohashi T; Eto Y; Saito T; Kira J; Yamada T Ann Neurol; 2000 May; 47(5):625-31. PubMed ID: 10805333 [TBL] [Abstract][Full Text] [Related]